Yicheng Bioelectronics Obtains RMB 70 Million VC Investment
This article was originally published in PharmAsia News
Beijing Yicheng Bioelectronics Technology recently completed its first round of private financing, led by Sequoia Capital China's RMB 70 million investment
You may also be interested in...
US FDA investigators' increased focus on aseptic operations is resulting in more Form 483 observations of microbiological contamination issues over the past few years.
Pfizer's COVID-19 vaccine is sure to dominate the third quarter results call, with everything from data to widescale distribution and the potential financial reward on the minds of investors and the public.
The company’s third-quarter sales were up 4% year-over-year as transcatheter aortic valve replacement procedure volumes returned to pre-pandemic levels.